Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-23 4:38 pm Purchase | 2022-08-22 | 13G | Minerva Neurosciences, Inc. NERV | Point72 Asset Management, L.P. | 470,000 8.800% | 470,000![]() (New Position) | Filing History |
| 2022-08-04 4:28 pm Purchase | 2022-08-03 | 13G | Merrimack Pharmaceuticals, Inc. MACK | Point72 Asset Management, L.P. | 900,981 6.700% | 900,981![]() (New Position) | Filing History |
| 2022-08-02 4:25 pm Purchase | 2022-08-01 | 13G | Otonomy, Inc. OTIC | Point72 Asset Management, L.P. | 5,450,000 9.600% | 5,450,000![]() (New Position) | Filing History |
| 2022-07-25 5:20 pm Purchase | 2022-07-15 | 13G | Achilles Therapeutics plc ACHL | Point72 Asset Management, L.P. | 2,081,050 5.300% | 2,081,050![]() (New Position) | Filing History |
| 2022-06-22 4:14 pm Purchase | 2022-06-21 | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management, L.P. | 2,067,874 5.100% | 729,206![]() (+54.47%) | Filing History |
| 2022-06-21 5:00 pm Purchase | 2022-06-17 | 13G | AxoGen, Inc. AXGN | Point72 Asset Management, L.P. | 2,111,663 5.000% | 2,111,663![]() (New Position) | Filing History |
| 2022-06-07 4:45 pm Purchase | 2022-05-27 | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management, L.P. | 3,117,480 5.100% | 3,117,480![]() (New Position) | Filing History |
| 2022-05-27 4:33 pm Purchase | 2022-05-26 | 13G | Tactile Systems Technology, Inc. TCMD | Point72 Asset Management, L.P. | 1,182,790 5.900% | 1,182,790![]() (New Position) | Filing History |
| 2022-02-18 5:17 pm Purchase | 2022-02-17 | 13G | IDEAYA Biosciences, Inc. IDYA | Point72 Asset Management, L.P. | 2,054,217 5.300% | 2,054,217![]() (New Position) | Filing History |
| 2022-02-14 5:26 pm Unchanged | 2021-12-31 | 13G | Blue Owl Capital Inc. OWL | Point72 Asset Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:50 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 10,610,000 9.100% | 3,710,331![]() (+53.78%) | Filing History |
| 2022-02-14 4:49 pm Purchase | 2021-12-31 | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management, L.P. | 1,860,670 7.500% | 517,428![]() (+38.52%) | Filing History |
| 2022-02-14 4:49 pm Sale | 2021-12-31 | 13G | Kindred Biosciences, Inc. KIN | Point72 Asset Management, L.P. | 0 0.000% | -3,858,103![]() (Position Closed) | Filing History |
| 2022-02-14 4:48 pm Sale | 2021-12-31 | 13G | Kadmon Holdings, Inc. KDMN | Point72 Asset Management, L.P. | 0 0.000% | -9,083,336![]() (Position Closed) | Filing History |
| 2022-02-14 4:47 pm Purchase | 2021-12-31 | 13G | Growth Capital Acquisition Corp. GCAC | Point72 Asset Management, L.P. | 1,491,609 8.600% | 411,185![]() (+38.06%) | Filing History |
| 2022-02-14 4:46 pm Sale | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | Point72 Asset Management, L.P. | 225,463 0.300% | -2,999,111![]() (-93.01%) | Filing History |
| 2022-02-14 4:45 pm Sale | 2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Point72 Asset Management, L.P. | 987,111 4.800% | -112,889![]() (-10.26%) | Filing History |
| 2022-02-14 4:44 pm Sale | 2021-12-31 | 13G | Oyster Point Pharma, Inc. OYST | Point72 Asset Management, L.P. | 2,104,202 8.000% | -193,559![]() (-8.42%) | Filing History |
| 2022-02-14 4:43 pm Sale | 2021-12-31 | 13G | Paya Holdings Inc. PAYA | Point72 Asset Management, L.P. | 494,000 0.400% | -5,965,793![]() (-92.35%) | Filing History |
| 2022-02-14 4:43 pm Purchase | 2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 6,312,371 9.700% | 788,465![]() (+14.27%) | Filing History |

